Cheyne Capital Management (Uk) LLP Albireo Pharma, Inc. Transaction History

Cheyne Capital Management (Uk) LLP

  • $26.1 Million
  • Q4 2023

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
BUY
$18.01 - $23.78 $240,685 - $317,795
13,364 New
13,364 $288,000

Others Institutions Holding ALBO

# of Institutions
4
Shares Held
865
Call Options Held
0
Put Options Held
0
View Full List

About ALBIREO PHARMA, INC.

ALBO Quotes by TradingView
  • Ticker ALBO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,612,500
  • Description
  • Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...
More about ALBO
Track This Portfolio

Track Cheyne Capital Management (Uk) LLP Portfolio

Follow Cheyne Capital Management (Uk) LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cheyne Capital Management (Uk) LLP, based on Form 13F filings with the SEC.

News

Stay updated on Cheyne Capital Management (Uk) LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email